VenatoRx Receives $9.4 Million from CARB-X to Develop a New Class of Antibiotic to Combat Multi-Drug Resistant Bacteria

See more here


VenatoRx Raises $42 Million Series B: Versant, Abingworth, Foresite Back Industry-Leading Antibiotics Developer

See more here


Relmada Therapeutics Appoints Dr. Maurizio Fava as Chair of the Dextromethadone Scientific Advisory Board for its Depression Program

See more here


Dr. Ottavio Vitolo Appointed Executive Clinical Advisor at Relmada Therapeutics

See more here


Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer 

See more here


Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors

See more here


Bainbridge Health launches InfusionWare Intelligence to Address Medication Safety Practices

See more here


The One Health Company Teams with the Johns Hopkins University School of Medicine to Advance Sarcoma Treatment for Dogs and Humans

See more here


Joe Biden Singles Out The One Health Company at SXSW Connect to End Cancer

See more here